Latest Profitability News

ASX Limited reveals steady progress on its FY28 strategy, emphasizing technology modernization and operational resilience while providing detailed financial guidance through FY27.

Cochlear Limited has lowered its FY25 earnings guidance due to slower-than-expected sales growth and a sharper decline in Services revenue. Despite this, implant unit growth remains on track, driven by emerging markets.

Clover Corporation has upgraded its FY25 earnings forecast, expecting net profit after tax to exceed market consensus by around 20%, driven by strong sales and operational improvements.

Tower Limited has confirmed Paul Johnston as its permanent CEO after a successful interim period, while initiating a search for a new CFO to sustain its financial leadership.

Asara Resources has received a significant cash payment from Teck Resources Chile following the resolution of a legal dispute, marking a key milestone in their joint venture for the Loreto Copper Project.

Qantas Group is closing its Singapore-based low-cost carrier Jetstar Asia, recycling $500 million in capital to support fleet renewal and growth in Australia and New Zealand. The move impacts only 16 intra-Asia routes and aims to strengthen core markets amid rising costs and competition.

Austin Engineering has raised its FY25 revenue guidance to $370 million, driven by strong growth in the Americas, but has lowered its EBIT forecast due to operational challenges in Chile.

Articore Group reaffirms its FY25 financial guidance while initiating a strategic review to unlock shareholder value, coinciding with the appointment of Vivek Kumar as Group CEO.

Perseus Mining outlines a robust five-year gold production plan targeting up to 2.7 million ounces with stable costs and strong cash margins, backed by major projects in Africa.

Little Green Pharma invites shareholders to a detailed FY2025 financial results webinar, promising insights into profitability, revenue growth, and recent financing achievements.

Monash IVF has disclosed a significant embryo transfer error at its Clayton laboratory, prompting an internal investigation and expanded independent review. The company is implementing new safeguards while maintaining its profit outlook.

Pure Foods Tasmania has raised $100,000 through a share placement and appointed directors to new operational roles aimed at driving sales growth and improving cost efficiency.